- Home
- ENOV
ENOV
Enovis Corporation
as 11-15-2024 4:00pm EST
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.2B | IPO Year: | 2008 |
| Target Price: | $67.44 | AVG Volume (30 days): | 764.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.27 - $65.03 | Next Earning Date: | 11-06-2024 |
| Revenue: | $2,001,668,000 | Revenue Growth: | 20.52% |
| Revenue Growth (this year): | 25.64% | Revenue Growth (next year): | 6.43% |
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
ENOV: Raising target price to $38.00
Zacks
8 days ago
Enovis (ENOV) Upgraded to Buy: Here's Why
Zacks
8 days ago
Wall Street Analysts Predict a 38.95% Upside in Enovis (ENOV): Here's What You Should Know
GuruFocus.com
10 days ago
Enovis Corp (ENOV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Thomson Reuters StreetEvents
10 days ago
Q3 2024 Enovis Corp Earnings Call
Zacks
10 days ago
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
MT Newswires
10 days ago
Enovis' Fiscal Q3 Adjusted Earnings, Revenue Rise; Fiscal 2024 Guidance Updated
Associated Press Finance
11 days ago
Enovis: Q3 Earnings Snapshot
Compare ENOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.